Michael N Robertson Selected Research

HIV Infections (HIV Infection)

1/2023	A Randomized, Double-Blind, Placebo-Controlled, Phase 1 Trial of Radiopaque Islatravir-Eluting Subdermal Implants for Pre-exposure Prophylaxis Against HIV-1 Infection.
1/2013	HIV-1 vaccine-induced T-cell responses cluster in epitope hotspots that differ from those induced in natural infection with HIV-1.
8/2012	Sexual risk behaviors, circumcision status, and preexisting immunity to adenovirus type 5 among men who have sex with men participating in a randomized HIV-1 vaccine efficacy trial: step study.
7/2012	Extended follow-up confirms early vaccine-enhanced risk of HIV acquisition and demonstrates waning effect over time among participants in a randomized trial of recombinant adenovirus HIV vaccine (Step Study).
2/2012	Low-dose penile SIVmac251 exposure of rhesus macaques infected with adenovirus type 5 (Ad5) and then immunized with a replication-defective Ad5-based SIV gag/pol/nef vaccine recapitulates the results of the phase IIb step trial of a similar HIV-1 vaccine.
8/2008	DNA gag/adenovirus type 5 (Ad5) gag and Ad5 gag/Ad5 gag vaccines induce distinct T-cell response profiles.
9/2007	Efficacy, safety, and tolerability of long-term combination antiretroviral therapy in asymptomatic treatment-naïve adults with early HIV infection.
7/2003	Indinavir did not further increase mean triglyceride levels in HIV-infected patients treated with nucleoside reverse transcriptase inhibitors: an analysis of three randomized clinical trials.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael N Robertson Research Topics

Disease

39	Infections 03/2023 - 04/2004
8	HIV Infections (HIV Infection) 01/2023 - 07/2003
8	Chronic Hepatitis C 11/2020 - 07/2015
8	Fibrosis (Cirrhosis) 01/2020 - 08/2014
3	Hepatitis C 01/2022 - 01/2016
3	Mycoses (Diseases, Fungus) 12/2017 - 07/2014
2	Communicable Diseases (Infectious Diseases) 01/2023 - 01/2012
2	Virus Diseases (Viral Diseases) 01/2019 - 02/2003
2	Coinfection 11/2017 - 08/2015
2	Viremia 03/2008 - 04/2004
1	Reinfection 01/2022
1	Chronic Renal Insufficiency 11/2020
1	Insulin Resistance 01/2018
1	Pneumonia (Pneumonitis) 01/2018
1	Chest Pain (Chest Pains) 01/2018
1	Cellulitis 01/2018
1	Opiate Overdose 01/2018
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 12/2017
1	Pain (Aches) 03/2014
1	Malaria 01/2012
1	Tuberculosis (Tuberculoses) 01/2012
1	Disease Progression 04/2011
1	HIV Seropositivity 12/2008
1	Fatigue 09/2007
1	Hyperlipidemias (Hyperlipidemia) 07/2003

Drug/Important Bio-Agent (IBA)

21	grazoprevirIBA 03/2023 - 08/2014
19	elbasvirIBA 03/2023 - 07/2015
13	VaccinesIBA 01/2013 - 04/2004
11	Ribavirin (Virazole)FDA LinkGeneric 03/2023 - 08/2014
9	Antiviral Agents (Antivirals)IBA 01/2022 - 09/2015
5	InterferonsIBA 01/2019 - 07/2015
4	uprifosbuvirIBA 01/2019 - 11/2017
4	ruzasvirIBA 01/2019 - 11/2017
4	RNA (Ribonucleic Acid)IBA 11/2017 - 04/2011
3	islatravirIBA 01/2023 - 01/2021
3	Lamivudine (Epivir)FDA Link 01/2022 - 07/2003
3	Opioid Analgesics (Opioids)IBA 01/2022 - 11/2016
3	Proteins (Proteins, Gene)FDA Link 01/2020 - 10/2017
3	posaconazole FDA Link 12/2017 - 07/2014
3	Protease Inhibitors (Protease Inhibitor)IBA 01/2016 - 07/2003
2	AIDS VaccinesIBA 01/2023 - 07/2012
2	AntigensIBA 01/2023 - 02/2003
2	doravirineIBA 01/2022 - 01/2021
2	DNA VaccinesIBA 03/2014 - 03/2008
1	Amino Acids FDA Link 03/2023
1	2'-deoxyadenosineIBA 01/2023
1	NucleosidesIBA 01/2021
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2021
1	NucleotidesIBA 01/2019
1	Oral ContraceptivesIBA 01/2019
1	Ethinyl Estradiol (Estinyl)FDA LinkGeneric 01/2019
1	Drug CombinationsIBA 01/2019
1	SofosbuvirIBA 01/2018
1	CreatinineIBA 01/2018
1	Proton Pump InhibitorsIBA 10/2017
1	N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA 09/2015
1	SimeprevirIBA 09/2015
1	telaprevirIBA 09/2015
1	SolutionsIBA 07/2014
1	CyclodextrinsIBA 07/2014
1	Phosphates (Orthophosphate)IBA 03/2014
1	EpitopesIBA 01/2013
1	AntibodiesIBA 07/2012
1	SAIDS VaccinesIBA 02/2012
1	Viral RNAIBA 02/2012
1	CytokinesIBA 11/2008
1	DNA (Deoxyribonucleic Acid)IBA 04/2004
1	Protein Subunits (Protein Subunit)IBA 04/2004
1	Indinavir (Crixivan)FDA Link 07/2003
1	Triglycerides (Triacylglycerol)IBA 07/2003
1	Zidovudine (Retrovir)FDA LinkGeneric 07/2003

Therapy/Procedure

10	Therapeutics 01/2022 - 07/2003
2	Aftercare (After-Treatment) 01/2022 - 07/2003
1	Opiate Substitution Treatment 01/2022
1	Hormone Replacement Therapy (Therapy, Hormone Replacement) 01/2019
1	Highly Active Antiretroviral Therapy (HAART) 09/2007